Apathy is Associated with Critical Psychological Determinants of Medication Adherence in HIV Disease

被引:13
作者
Babicz, Michelle A. [1 ]
Woods, Steven Paul [1 ]
Fazeli, Pariya [2 ]
Morgan, Erin E. [3 ]
机构
[1] Univ Houston, Dept Psychol, 126 Heyne Bldg,Suite 204, Houston, TX 77004 USA
[2] Univ Alabama Birmingham, Sch Nursing, Birmingham, AL USA
[3] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
关键词
HIV; AIDS; Apathy; Motivation; Neuropsychiatry; Medication adherence; QUALITY-OF-LIFE; COGNITIVE PERFORMANCE; BRAIN-INJURY; VALIDITY; DEPRESSION; SYMPTOMS; THERAPY; IMPAIRMENT; DISORDERS; EFFICACY;
D O I
10.1007/s10880-020-09715-7
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Apathy is common in HIV, separable from depression, and has been associated with non-adherence to antiretroviral therapy (ART). We examined the associations between apathy and critical psychological determinants of ART adherence, as per the information-motivation-behavioral model, in 85 persons living with HIV. Apathy was measured using a composite of the apathy subscale of the Frontal Systems Behavioral Scale and the vigor-activation scale of the Profile of Mood States. Independent of major depressive disorder, apathy was related at small-to-medium effect sizes with motivation to adhere and self-efficacy for health-related decision-making and medication management, but not with HIV knowledge or medication management skills. These findings suggest that apathy plays a unique role in several critical health adherence determinants and support the importance of assessment and management of apathy to maximize health outcomes among individuals with HIV disease.
引用
收藏
页码:301 / 312
页数:12
相关论文
共 67 条
[1]  
American Psychiatric Association, 2015, DEPR DIS DSM 5 SEL
[2]  
[Anonymous], 1981, Profile of mood states questionnaire
[3]   The role of the dorsal striatum in reward and decision-making [J].
Balleine, Bernard W. ;
Delgado, Mauricio R. ;
Hikosaka, Okihide .
JOURNAL OF NEUROSCIENCE, 2007, 27 (31) :8161-8165
[4]   Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status [J].
Barclay, Terry R. ;
Hinkin, Charles H. ;
Castellon, Steven A. ;
Mason, Karen I. ;
Reinhard, Matthew J. ;
Marion, Sarah D. ;
Levine, Andrew J. ;
Durvasula, Ramani S. .
HEALTH PSYCHOLOGY, 2007, 26 (01) :40-49
[5]   Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia [J].
Bodkin, JA ;
Siris, SG ;
Bermanzohn, PC ;
Hennen, J ;
Cole, JO .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (02) :388-390
[6]   Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection [J].
Carey, CL ;
Woods, SP ;
Gonzalez, R ;
Conover, E ;
Marcotte, TD ;
Grant, I ;
Heaton, RK .
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (03) :307-319
[7]   Development and psychometric evaluation of the brief HIV knowledge questionnaire [J].
Carey, MP ;
Schroder, KEE .
AIDS EDUCATION AND PREVENTION, 2002, 14 (02) :172-182
[8]   Apathy, depression, and cognitive performance in HIV-1 infection [J].
Castellon, SA ;
Hinkin, CH ;
Wood, S ;
Yarema, KT .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1998, 10 (03) :320-329
[9]   Are the available apathy measures reliable and valid? A review of the psychometric evidence [J].
Clarke, Diana E. ;
Ko, Jean Y. ;
Kuhl, Emily A. ;
van Reekum, Robert ;
Salvador, Rocio ;
Marin, Robert S. .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2011, 70 (01) :73-97
[10]   PHYSICIANS CHARACTERISTICS INFLUENCE PATIENTS ADHERENCE TO MEDICAL-TREATMENT - RESULTS FROM THE MEDICAL OUTCOMES STUDY [J].
DIMATTEO, MR ;
SHERBOURNE, CD ;
HAYS, RD ;
ORDWAY, L ;
KRAVITZ, RL ;
MCGLYNN, EA ;
KAPLAN, S ;
ROGERS, WH .
HEALTH PSYCHOLOGY, 1993, 12 (02) :93-102